Item no. |
ELS-PKSH033615-50ug |
Manufacturer |
Elabscience
|
Amount |
50ug |
Category |
|
Type |
Proteins |
Specific against |
Human |
Host |
E.coli |
ECLASS 10.1 |
32160409 |
ECLASS 11.0 |
32160409 |
UNSPSC |
12352202 |
Alias |
Interleukin-36 Alpha, FIL1 Epsilon, Interleukin-1 Epsilon, IL-1 Epsilon, Interleukin-1 Family Member 6, IL-1F6, IL36A, FIL1E, IL1E, IL1F6 |
Similar products |
IL36A, IL1F6, FIL1E, IL-1F6, IL1E, Interleukin-36 Alpha, FIL1 Epsilon, Interleukin-1 Epsilon, IL-1 Epsilon, Interleukin-1 Family Member 6 |
Available |
|
Synonym |
Interleukin-36 Alpha, FIL1 Epsilon, Interleukin-1 Epsilon, IL-1 Epsilon, Interleukin-1 Family Member 6, IL-1F6, IL36A, FIL1E, IL1E, IL1F6 |
Storage |
according to manual |
Protein Construction |
Recombinant Human IL36A is produced by our E.coli expression system and the target gene encoding Met1-Phe158 is expressed. |
Sequence |
Met1-Phe158 |
Accession |
Q9UHA7 |
Shipping |
This product is provided as lyophilized powder which is shipped with ice packs. |
Purity |
> 95% as determined by reducing SDS-PAGE. |
Endotoxin |
< 1.0 EU per ug as determined by the LAL method. |
Stability and Storage |
Lyophilized proteins are stable for up to 12 months when stored at -20 to -80CC. Reconstituted protein solution can be stored at 4-8C for 2-7 days. Aliquots of reconstituted samples are stable at < -20C for 3 months. |
Mol Mass |
17.7 kDa |
AP Mol Mass |
16 kDa |
Formulation |
Lyophilized from a 0.2 um filtered solution of PBS; PH7.4. |
Reconstitution |
Please refer to the printed manual for detailed information. |
Background |
Human Interleukin-36alpha (IL-36alpha) is a secreted cytokine that belongs to the Interleukin 1 cytokine family. IL-36alpha is expressed in the immune system and the fetal brain; but not in other tissues or multiple hematopoietic cell lines. IL-36alpha is the only IL-1 family member found to be expressed on T-cells. IL-36alpha and IL-1F8 are involved in the regulation of adipose tissue gene expression. Importantly; IL-36alpha inhibits PPARgamma expression; which may lead to a reduction in adipocyte differentiation suggesting metabolic effects of this cytokine. IL-36alpha; along with IL-1F8 and IL-1F9; has been shown to act as an agonist by activating the pathway involving NFkappaB and MAPK in an IL-1Rrp2 dependent manner. This suggest that IL-36alpha may signal in a similar fashion to IL-1 and IL-18 in having a binding receptor which upon ligation; recruits a second receptor as a signaling component; forming an active heterodimeric receptor complex. |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.